Anal Fissure Clinical Trial
Official title:
A Phase 4, Multiple-dose, Pharmacokinetic, Safety, and Exploratory Efficacy Study of Nitroglycerin Ointment 0.4% (RECTIV®) in Adolescents (Age ≥12 to <17 Years) With Moderate to Severe Pain Due to Chronic Anal Fissure
RECTIV® is an ointment containing 0.4% nitroglycerin (NTG) for the treatment of moderate to severe pain associated with chronic anal fissure approved in June 2011 by the US Food and Drug Administration (FDA) for adults. The purpose of this study is to assess the safety, pharmacokinetics, and exploratory efficacy of RECTIV® in adolescents
This is an open-label, multicenter study conducted in up to 10 sites in the United States. A total of 13 pediatric male or female patients age ≥12 to <17 years will be enrolled. The patients will administer a dose of Rectiv® twice daily to characterize the safety, pharmacokinetics , and exploratory efficacy of Nitroglycerin Ointment 0.4% (RECTIV® )over 5 days ;
Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06216223 -
Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients
|
N/A | |
| Not yet recruiting |
NCT05405634 -
Microbiota in Chronic Anal Fissure and Its Association With Prognosis
|
||
| Completed |
NCT05736926 -
Anal Fissure Among Survivors of COVID-19 Virus Infection.
|
||
| Enrolling by invitation |
NCT00980369 -
The Importance of Lateral Internal Sphincterotomy Incision: Parallel or Vertical
|
N/A | |
| Completed |
NCT05616455 -
Efficacy and Safety of Propionibacterium Extract Gel Versus 0.4% Glyceryl Trinitrate Ointment in the Treatment of Chronic Anal Fissure: a Randomised Controlled Trial
|
Phase 4 | |
| Completed |
NCT04173130 -
Monocentric Feasibility Study for a New Medical Device for the Treatment of Anal Fissure With Botulinum Toxin
|
N/A | |
| Completed |
NCT03345511 -
Ultrasound Guided Caudal Block for Benign Anal Surgery
|
N/A | |
| Completed |
NCT05341180 -
Efficacy of Polyethylene Glycol vs Lactulose With Isabgol in Acute Fissure-in-Ano: PEGASIS Trial
|
Phase 2/Phase 3 | |
| Completed |
NCT03528772 -
Topical Minoxidil Versus Topical Glyceryl Trinitrate in Treatment of Chronic Anal Fissure
|
N/A | |
| Active, not recruiting |
NCT04428697 -
Sungurtekin Technique vs. Closed Lateral Internal Sphincterotomy Technique
|
N/A | |
| Terminated |
NCT02023047 -
An Open Label Multi-Dose Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing
|
Phase 1/Phase 2 | |
| Recruiting |
NCT01039051 -
Diet and Lifestyle Intervention Study in Postpartum Women in China
|
Phase 2/Phase 3 | |
| Completed |
NCT00210444 -
Efficacy Study of Dysport® in the Treatment of Anal Fissure.
|
Phase 2 | |
| Completed |
NCT00827736 -
Comparison of Treatment Success of Botox Injection in the Internal Sphincter Versus Isosorbidedinitrate Ointment in Patients With an Anal Fissure
|
Phase 4 | |
| Withdrawn |
NCT02667535 -
PK, PD and Safety Comparative Trial of Isosorbide Mononitrate Gel in Healthy Participants and With Anal Fissure
|
Phase 1 | |
| Not yet recruiting |
NCT06049524 -
Could Preoperative Assessment of Physical and Psychological Status Help Predict Pain After Anorectal Surgery?
|
||
| Not yet recruiting |
NCT05709717 -
Regenerative Therapy With Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cells and Platelet-rich Plasma to Treat Complex Perianal Diseases
|
||
| Completed |
NCT05038605 -
Topical vs Oral Metronidazole After Benign Anorectal Surgery
|
N/A | |
| Not yet recruiting |
NCT03780998 -
Effects of Sodium Pentaborat Based Gel on Perianal Benign Diseases
|
||
| Completed |
NCT03426449 -
Posterolateral Versus Lateral Internal Anal Sphincterotomy for Chronic Anal Fissure
|
N/A |